Lih‐Ming Wong

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis et al. · The Lancet · 2020 · 2K citations

Medicine, Nuclear Medicine, Oncology +17

Malignant Ureteral Obstruction: Outcomes After Intervention. Have Things Changed?

Lih‐Ming Wong, Laurence K. Cleeve, Alvin Milner et al. · The Journal of Urology · 2007 · 150 citations

Medicine, Oncology, Surgery +12

Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma—The RAPPORT Trial

Shankar Siva, Mathias Bressel, Simon Wood et al. · European Urology · 2021 · 149 citations

Medicine, Oncology, Radiation Oncology +13

Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial

Shankar Siva, Mathias Bressel, Mark Sidhom et al. · The Lancet Oncology · 2024 · 105 citations

Medicine, Oncology, Radiation Oncology +13

Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: Establishing a dose–response relationship

Shankar Siva, Price Jackson, Tomas Kron et al. · Radiotherapy and Oncology · 2016 · 82 citations

Medicine, Oncology, Radiation Oncology +16